Cyteir completes financing to advance novel cancer therapies
![](https://www.blackpointgroup.com/wp-content/uploads/2014/07/Cytier-Series-B-xWEB-1-784x440.jpg)
- 08
- 03
- 2018
- Category:
- Entrepreneurship
Cyteir completes financing to advance novel cancer therapies
By David E Shaw
As a co-founder of Cyteir Therapeutics, and chair emeritus of The Jackson Laboratory, I’m pleased to share this news about our Series B financing to advance novel cancer therapies. Cyteir was launched with technological breakthroughs discovered at The Jackson Laboratory.